Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: the Munich General Practitioner Project - PubMed (original) (raw)
Comparative Study
. 1996 Dec;39(12):1540-5.
doi: 10.1007/s001250050612.
Affiliations
- PMID: 8960840
- DOI: 10.1007/s001250050612
Comparative Study
Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: the Munich General Practitioner Project
E Standl et al. Diabetologia. 1996 Dec.
Abstract
The 10-year follow-up of the Munich General Practitioner Project was designed as a long-term prospective study to evaluate factors predicting macrovascular and overall mortality in a random cohort of non-insulin-dependent diabetic (NIDDM) patients. Of the original 290 patients (103 males, 187 females, median age 65 years) 92.5% could be assessed, 103 subjects had died, 58 from macrovascular causes. In an univariate analysis of baseline data, deceased patients, and especially those who died from macrovascular causes had significantly higher fasting blood glucose, HbA1c, von Willebrand-factor protein, urine albumin excretion, and serum beta 2-microglobulin, were significantly older, exhibited significantly more ischaemic heart disease (abnormal ECG Minnesota codes), carotid artery and peripheral vascular disease (both determined by ultrasound-Doppler), and had significantly inferior knowledge about diabetes and its treatment. No significant differences were seen for gender, blood pressure, smoking, total cholesterol, triglycerides, HDL-cholesterol, or the use of antidiabetic, antihypertensive or coronary drugs. In a multiple logistic regression analysis, the risk factors for macrovascular death were age, HbA1c and von Willebrand-factor protein. When baseline macrovascular disease was taken into account, carotid artery disease was also a determinant. The main variables from the metabolic syndrome (blood pressure, dyslipidaemia, body mass index) did not enter a multiple logistic regression analysis. The data suggest that age and haemoglobin A1c are major determinants, and that in addition von Willebrand-factor associated endothelial damage is a risk factor for macrovascular mortality in NIDDM patients.
Similar articles
- Plasma lipoproteins, apoproteins and cardiovascular disease in type 2 diabetic patients. A nine-year follow-up study.
Roselli della Rovere G, Lapolla A, Sartore G, Rossetti C, Zambon S, Minicuci N, Crepaldi G, Fedele D, Manzato E. Roselli della Rovere G, et al. Nutr Metab Cardiovasc Dis. 2003 Feb;13(1):46-51. doi: 10.1016/s0939-4753(03)80167-9. Nutr Metab Cardiovasc Dis. 2003. PMID: 12772437 - Development of macrovascular diseases in NIDDM patients in northern Taiwan. A 4-yr follow-up study.
Fu CC, Chang CJ, Tseng CH, Chen MS, Kao CS, Wu TJ, Wu HP, Chuang LM, Chen CJ, Tai TY. Fu CC, et al. Diabetes Care. 1993 Jan;16(1):137-43. doi: 10.2337/diacare.16.1.137. Diabetes Care. 1993. PMID: 8422768 - Relationship of elevated urinary albumin excretion to components of the metabolic syndrome in non-insulin-dependent diabetes mellitus.
Abuaisha B, Kumar S, Malik R, Boulton AJ. Abuaisha B, et al. Diabetes Res Clin Pract. 1998 Feb;39(2):93-9. doi: 10.1016/s0168-8227(97)00111-3. Diabetes Res Clin Pract. 1998. PMID: 9597378 - Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects.
Uusitupa MI, Niskanen LK, Siitonen O, Voutilainen E, Pyörälä K. Uusitupa MI, et al. Diabetologia. 1993 Nov;36(11):1175-84. doi: 10.1007/BF00401063. Diabetologia. 1993. PMID: 8270133
Cited by
- Diabetic Vasculopathy: Molecular Mechanisms and Clinical Insights.
Jia G, Bai H, Mather B, Hill MA, Jia G, Sowers JR. Jia G, et al. Int J Mol Sci. 2024 Jan 9;25(2):804. doi: 10.3390/ijms25020804. Int J Mol Sci. 2024. PMID: 38255878 Free PMC article. Review. - Precision prognostics for cardiovascular disease in Type 2 diabetes: a systematic review and meta-analysis.
Ahmad A, Lim LL, Morieri ML, Tam CH, Cheng F, Chikowore T, Dudenhöffer-Pfeifer M, Fitipaldi H, Huang C, Kanbour S, Sarkar S, Koivula RW, Motala AA, Tye SC, Yu G, Zhang Y, Provenzano M, Sherifali D, de Souza RJ, Tobias DK; ADA/EASD PMDI; Gomez MF, Ma RCW, Mathioudakis N. Ahmad A, et al. Commun Med (Lond). 2024 Jan 22;4(1):11. doi: 10.1038/s43856-023-00429-z. Commun Med (Lond). 2024. PMID: 38253823 Free PMC article. - An Evaluation of Alternative Technology-Supported Counseling Approaches to Promote Multiple Lifestyle Behavior Changes in Patients With Type 2 Diabetes and Chronic Kidney Disease.
St-Jules DE, Hu L, Woolf K, Wang C, Goldfarb DS, Katz SD, Popp C, Williams SK, Li H, Jagannathan R, Ogedegbe O, Kharmats AY, Sevick MA. St-Jules DE, et al. J Ren Nutr. 2023 Jan;33(1):35-44. doi: 10.1053/j.jrn.2022.05.006. Epub 2022 Jun 22. J Ren Nutr. 2023. PMID: 35752400 Free PMC article. Clinical Trial. - Relationship between hemoglobin A1c level and flow-mediated vasodilation in patients with type 2 diabetes mellitus receiving antidiabetic drugs.
Yamaji T, Harada T, Hashimoto Y, Nakano Y, Kajikawa M, Yoshimura K, Aoki G, Chayama K, Goto C, Mizobuchi A, Han Y, Yusoff FM, Kishimoto S, Maruhashi T, Nakashima A, Higashi Y. Yamaji T, et al. J Diabetes Investig. 2022 Apr;13(4):677-686. doi: 10.1111/jdi.13705. Epub 2021 Nov 29. J Diabetes Investig. 2022. PMID: 34725937 Free PMC article. - Comparative effects of insulin glulisine and lispro on postprandial plasma glucose and lipid profile in Japanese patients with type 2 diabetes mellitus.
Yamada M, Suzuki J, Nakaya T, Ichikawa M, Yamamoto K, Imagawa M, Sato S, Fujii M, Zenimaru Y, Konoshita T, Ishizuka T. Yamada M, et al. Diabetol Int. 2020 Nov 17;12(3):330-335. doi: 10.1007/s13340-020-00475-1. eCollection 2021 Jul. Diabetol Int. 2020. PMID: 34150441 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials